ME Therapeutics Holdings Inc. Stock
Stocks
METX
CA5527671054
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.500 CAD | -17.76% |
|
-.--% | -37.50% |
| 07-17 | ME Therapeutics Holdings Inc. announced that it has received CAD 0.576501 million in funding | CI |
| 07-17 | ME Therapeutics Raises C$0.58 Million Via Non-Brokered Private Placement | MT |
| Market Cap | 75.12M 53.55M 46.5M 43.22M 39.75M 5.11B 76.38M 510M 200M 2.55B 201M 197M 8.43B | P/E 2024 |
-51.7x | P/E 2025 | -93.2x |
|---|---|---|---|---|---|
| Enterprise Value | 73.79M 52.6M 45.67M 42.46M 39.05M 5.02B 75.02M 501M 196M 2.5B 198M 193M 8.28B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
44.63% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -17.76% | ||
| Current month | +25.63% | ||
| 1 month | +25.63% | ||
| 6 months | +13.64% | ||
| Current year | -37.50% |
| 1 month | 1.9 |  | 3.04 |
| Current year | 0.79 | | 3.8 |
| 1 year | 0.79 | | 8 |
| 3 years | 0.05 | | 11 |
| 5 years | 0.05 | | 11 |
| 10 years | 0.05 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Salim Dhanji
CEO | Chief Executive Officer | 46 | 2023-03-08 |
Quinn Martin
DFI | Director of Finance/CFO | 44 | 2023-03-08 |
Karim Lalji
PRN | Corporate Officer/Principal | - | 2024-10-24 |
| Director | Title | Age | Since |
|---|---|---|---|
John Priatel
BRD | Director/Board Member | 60 | 2023-03-08 |
Salim Dhanji
BRD | Director/Board Member | 46 | 2023-03-08 |
Kenneth Harder
BRD | Director/Board Member | 59 | 2023-03-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/16/26 | Option | Director | 294,118 | 0.9788% | ||
| 7/16/26 | Sell | Director | 294,118 | 0.9788% | ||
| 7/16/26 | Option | Chief Financial Officer | 125,000 | 0.4160% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -17.76% | -.--% | -47.92% | - | 53.61M | |
| -1.40% | +3.69% | -2.09% | +11.41% | 49.37B | |
| -1.16% | +13.36% | +22.70% | +3.92% | 39.14B | |
| -2.41% | -0.65% | +406.63% | +629.40% | 40.85B | |
| -1.88% | -3.29% | +5.36% | +40.37% | 35.81B | |
| -1.74% | +8.42% | +8.85% | +48.87% | 30.5B | |
| -2.85% | -3.46% | - | - | 16.55B | |
| -0.21% | -4.74% | +31.83% | +126.49% | 16.14B | |
| -1.19% | -3.97% | -9.88% | -35.13% | 12.77B | |
| -0.64% | +3.09% | +3.15% | +9.37% | 13.71B | |
| Average | -3.12% | +5.20% | +46.51% | +104.34% | 25.49B | |
| Weighted average by Cap. | -1.60% | +6.71% | +76.73% | +130.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.29M -923K -801K -745K -685K -88.05M -1.32M -8.78M -3.45M -43.89M -3.47M -3.39M -145M | -1.19M -851K -739K -687K -631K -81.15M -1.21M -8.09M -3.18M -40.45M -3.2M -3.13M -134M |
| Net Debt | -1.5M -1.07M -926K -861K -792K -102M -1.52M -10.15M -3.98M -50.74M -4.01M -3.92M -168M | -1.33M -949K -824K -766K -704K -90.54M -1.35M -9.03M -3.54M -45.13M -3.57M -3.49M -149M |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- METX Stock
Select your edition
All financial news and data tailored to specific country editions
